By GINA KOLATA
Patients who took the drug, Repatha, were significantly less likely to have heart attacks or strokes, researchers concluded. But its high cost will be an issue.
Published: March 16, 2017 at 08:00PM
from NYT Health http://ift.tt/2mA2aWh
via IFTTT
from WordPress http://ift.tt/2mCrj3K
via IFTTT
No comments:
Post a Comment